title: Genotype and age at Parkinson disease diagnosis.
abstract: Parkinson disease (PD) is a degenerative movement disorder that results from the destruction of dopaminergic neurons in the midbrain substantia nigra. Both genetic and environmental factors contribute to PD risk, and likely to age at diagnosis. Among 258 newly diagnosed non-Hispanic Caucasian cases from Group Health Cooperative in western Washington State, we assessed whether diagnosis age was associated with 1,327 single nucleotide polymorphisms in genes related to central nervous system function, oxidative stress, inflammation or metal transport. We conducted linear regression to assess the age difference per variant allele while adjusting for sex and smoking. Of the polymorphisms associated with PD diagnosis age (ptrend<0.05), three demonstrated similar associations among 64 PD cases from the University of Washington Neurology Clinic, were not similarly associated (pinteraction<0.05) with age in general among 436 unrelated non-Hispanic Caucasian controls from the source population, and were predicted to be functional according to a public National Institute of Environmental Health Sciences polymorphism database. The most robust association was for rs10889162, a polymorphism in a predicted transcription factor binding site -582 bp from CYP2J2 arachidonic acid epoxygenase. Each variant allele was associated with 5.04 years older diagnosis age (95% confidence interval 2.28-7.80, p=0.0003). This association did not vary by sex or smoking history. Polymorphisms in predicted microRNA binding sites in GSTM5 and SLC11A2 were also associated with >2-year differences in diagnosis age. These results await confirmation in other series of incident cases, but suggest that selected genes and environmental exposures may influence PD diagnosis age.
authors.affiliation: University of Washington, Department of Environmental and Occupational Health Sciences Seattle, WA, USA.
authors.forename: Susan
authors.initials: S
authors.lastname: Searles Nielsen
authors.forename: Theo K
authors.initials: TK
authors.lastname: Bammler
authors.forename: Lisa G
authors.initials: LG
authors.lastname: Gallagher
authors.forename: Federico M
authors.initials: FM
authors.lastname: Farin
authors.forename: Wt
authors.initials: W
authors.lastname: Longstreth
authors.forename: Gary M
authors.initials: GM
authors.lastname: Franklin
authors.forename: Phillip D
authors.initials: PD
authors.lastname: Swanson
authors.forename: Harvey
authors.initials: H
authors.lastname: Checkoway
keywords: Arachidonic acid; CYP2J2 protein; CYP3A7 protein; GSTM5 protein; SLC11A2 protein; divalent metal transporter-1; idiopathic Parkinson disease; linoleic acid
references.citation: Neurol Clin. 2011 Aug;29(3):657-65
references.pmid: 21803216
references.citation: Am J Hum Genet. 2005 Aug;77(2):252-64
references.pmid: 15986317
references.citation: Am J Epidemiol. 2002 Apr 15;155(8):732-8
references.pmid: 11943691
references.citation: Emerg Themes Epidemiol. 2007 Apr 04;4:1
references.pmid: 17408493
references.citation: Neurosci Lett. 2011 Sep 1;501(3):128-31
references.pmid: 21777657
references.citation: Am J Epidemiol. 2003 Jun 1;157(11):1015-22
references.pmid: 12777365
references.citation: J Clin Epidemiol. 2002 Jan;55(1):25-31
references.pmid: 11781119
references.citation: Am J Hum Genet. 2005 Nov;77(5):685-93
references.pmid: 16252231
references.citation: Arch Neurol. 2009 Nov;66(11):1353-8
references.pmid: 19901166
references.citation: Eur J Epidemiol. 2011 Jun;26 Suppl 1:S1-58
references.pmid: 21626386
references.citation: J Mol Neurosci. 2011 Mar;43(3):246-50
references.pmid: 20589538
references.citation: Br J Pharmacol. 2010 Apr;159(7):1440-9
references.pmid: 20180943
references.citation: Brain Pathol. 2008 Jan;18(1):130-8
references.pmid: 18226108
references.citation: Am J Epidemiol. 2010 Dec 15;172(12):1357-63
references.pmid: 20959505
references.citation: Clin Neurosci Res. 2006 Dec 6;6(5):261-281
references.pmid: 18060039
references.citation: Autophagy. 2012 Apr;8(4):692-3
references.pmid: 22441017
references.citation: Nucleic Acids Res. 2009 Jul;37(Web Server issue):W600-5
references.pmid: 19417063
references.citation: Drug Metab Dispos. 2009 Jul;37(7):1528-38
references.pmid: 19359404
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B(7):1022-3
references.pmid: 19152345
references.citation: Lancet. 1991 Jun 1;337(8753):1321-4
references.pmid: 1674304
references.citation: Am J Hum Genet. 2002 May;70(5):1089-95
references.pmid: 11920285
references.citation: Neuroscience. 2012 Jun 1;211:51-76
references.pmid: 22108613
references.citation: Hum Genet. 2005 Jun;117(1):27-33
references.pmid: 15827745
references.citation: Biochem Pharmacol. 2003 Jul 1;66(1):1-13
references.pmid: 12818360
references.citation: J Parkinsons Dis. 2012;2(4):321-31
references.pmid: 23938262
references.citation: Pharmacol Ther. 2012 Feb;133(2):142-50
references.pmid: 22008259
references.citation: BMC Med Genet. 2009 Sep 22;10:98
references.pmid: 19772629
references.citation: Toxicol Sci. 1999 Jun;49(2):156-64
references.pmid: 10416260
references.citation: Biochem Soc Trans. 2012 Oct;40(5):1080-5
references.pmid: 22988869
references.citation: J Neurosci Res. 2003 Mar 15;71(6):863-70
references.pmid: 12605413
references.citation: J Neurochem. 2012 Aug;122(3):650-8
references.pmid: 22639965
references.citation: J Pharmacol Exp Ther. 2011 Nov;339(2):451-63
references.pmid: 21846841
references.citation: Hum Mol Genet. 2013 Feb 1;22(3):608-20
references.pmid: 23125283
references.citation: Biochem J. 1997 May 15;324 ( Pt 1):25-8
references.pmid: 9164836
references.citation: Pharmacogenet Genomics. 2011 May;21(5):308-11
references.pmid: 20739908
references.citation: Ann Hum Genet. 2011 Mar;75(2):201-10
references.pmid: 21309754
references.citation: J Parkinsons Dis. 2012;2(4):303-8
references.pmid: 23938260
references.citation: Arch Neurol. 2012 May;69(5):601-7
references.pmid: 22213411
references.citation: Ann Neurol. 2012 Jun;71(6):776-84
references.pmid: 22083847
references.citation: J Neurol Neurosurg Psychiatry. 2012 Jun;83(6):607-11
references.pmid: 22362919
references.citation: Acta Neurol Scand. 2013 May;127(5):295-300
references.pmid: 22957805
references.citation: Hum Mol Genet. 2012 Nov 15;21(22):4996-5009
references.pmid: 22892372
references.citation: Neurology. 2004 May 11;62(9):1616-8
references.pmid: 15136695
references.citation: PLoS Genet. 2012;8(3):e1002548
references.pmid: 22438815
references.citation: Am J Hum Genet. 2002 Apr;70(4):985-93
references.pmid: 11875758